C Meneghetti

637 total citations
10 papers, 528 citations indexed

About

C Meneghetti is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, C Meneghetti has authored 10 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 5 papers in Biotechnology. Recurrent topics in C Meneghetti's work include Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (5 papers) and Hematopoietic Stem Cell Transplantation (3 papers). C Meneghetti is often cited by papers focused on Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (5 papers) and Hematopoietic Stem Cell Transplantation (3 papers). C Meneghetti collaborates with scholars based in United States and Canada. C Meneghetti's co-authors include CF LeMaistre, Thasia Woodworth, K Parker, A. B. Deisseroth, Michael G. Rosenblum, James M. Reuben, James O. Shaw, C. Frederick LeMaistre, Elizabeth A. Saria and Jeffrey Drajesk and has published in prestigious journals such as The Lancet, Blood and Breast Cancer Research and Treatment.

In The Last Decade

C Meneghetti

10 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Meneghetti United States	9	382	187	126	99	97	10	528
K Parker United States	7	487 1.3×	259 1.4×	95 0.8×	116 1.2×	133 1.4×	11	598
CF LeMaistre United States	11	537 1.4×	209 1.1×	209 1.7×	132 1.3×	194 2.0×	18	903
Athanasia Syrengelas United States	6	590 1.5×	35 0.2×	259 2.1×	219 2.2×	25 0.3×	6	764
Hirofumi Koshiba Japan	13	276 0.7×	23 0.1×	155 1.2×	157 1.6×	18 0.2×	33	545
Jack Treml United States	10	284 0.7×	31 0.2×	85 0.7×	79 0.8×	11 0.1×	14	434
Paul Sims United States	10	247 0.6×	53 0.3×	105 0.8×	213 2.2×	5 0.1×	14	762
Jean-Pierre Aubry Switzerland	8	464 1.2×	10 0.1×	67 0.5×	143 1.4×	22 0.2×	8	688
Jean‐Paul Rivals Switzerland	12	774 2.0×	26 0.1×	461 3.7×	20 0.2×	42 0.4×	16	1.1k
H Umadome Japan	10	432 1.1×	14 0.1×	91 0.7×	36 0.4×	15 0.2×	17	570
Heather Pope United Kingdom	11	899 2.4×	19 0.1×	115 0.9×	183 1.8×	12 0.1×	17	1.2k

Countries citing papers authored by C Meneghetti

Since Specialization

Citations

This map shows the geographic impact of C Meneghetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Meneghetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Meneghetti more than expected).

Fields of papers citing papers by C Meneghetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Meneghetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Meneghetti. The network helps show where C Meneghetti may publish in the future.

Co-authorship network of co-authors of C Meneghetti

This figure shows the co-authorship network connecting the top 25 collaborators of C Meneghetti. A scholar is included among the top collaborators of C Meneghetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Meneghetti. C Meneghetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

LeMaistre, C. Frederick, C Meneghetti, L. G. Howes, & C. Kent Osborne. (1994). Targeting the EGF receptor in breast cancer treatment. Breast Cancer Research and Treatment. 32(1). 97–103. 36 indexed citations

2.

LeMaistre, C. Frederick, Fiona E. Craig, C Meneghetti, et al.. (1993). Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers.. PubMed. 53(17). 3930–4. 70 indexed citations

3.

LeMaistre, CF, C Meneghetti, Michael G. Rosenblum, et al.. (1992). Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood. 79(10). 2547–2554. 104 indexed citations

4.

Yau, Jonathan C., S. Huan, C. Frederick LeMaistre, et al.. (1992). Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation. American Journal of Hematology. 41(1). 40–44. 19 indexed citations

5.

LeMaistre, CF, C Meneghetti, Michael G. Rosenblum, et al.. (1992). Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood. 79(10). 2547–2554. 134 indexed citations

6.

Yau, Jonathan C., Meletios Α. Dimopoulos, S. Huan, et al.. (1991). Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation. European Journal Of Haematology. 47(5). 371–376. 20 indexed citations

7.

LeMaistre, CF, C Meneghetti, A. B. Deisseroth, et al.. (1991). Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia. The Lancet. 337(8750). 1124–1125. 29 indexed citations

8.

LeMaistre, CF, Steven T. Rosen, A Frankel, et al.. (1991). Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T- cell lymphoma. Blood. 78(5). 1173–1182. 7 indexed citations

9.

LeMaistre, CF, Steven T. Rosen, A Frankel, et al.. (1991). Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T- cell lymphoma. Blood. 78(5). 1173–1182. 93 indexed citations

10.

Yau, Jonathan C., C.F. LeMaistre, Gunar K. Zagars, et al.. (1990). Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease.. PubMed. 5(4). 269–72. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact